Access all articles for free at:
Vaccine, Vol. 35, Supplement 1, pp. A1-A62 (20 January 2017)
The Lancet Commission on Investing in Health has identified an opportunity for a “grand convergence” in public health. In this vision, infections and child and maternal mortality in low- and middle-income countries (LMIC) will approach the rates achieved in the developed world, thus eliminating the gap in health between rich and poor countries. In July of 2015, a conference was held in Siena Italy to discuss how to best make these decisions and to address current barriers to appropriate decision making such as lack of synchrony between vaccine developers and public health bodies responsible for implementation. Manuscripts in this supplement were derived from lectures and workshops from the meeting. It is hoped that taken together, these manuscripts and the points they raise will further the goal of a more transparent, efficient and fair vaccine decision process.